Intracavernous injection: a treatment modality for erectile dysfunction

被引：0
|
作者：
Uche-Holub, E. [1 ]
Thierling, U. [1 ]
Giessing, M. [2 ]
Neumann, N. J. [1 ]
机构：
[1] Univ Klinikum Dusseldorf, Hautklin, D-40225 Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Urol Klin, D-40225 Dusseldorf, Germany
来源：
HAUTARZT | 2013年 / 64卷 / 04期
关键词：
International index of erectile function; Intracavernous injection; Penile prosthesis; Phosphodiesterase type 5; Vacuum erection device;
D O I：
10.1007/s00105-013-2558-5
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
A 56-year-old man presented with a 12-year history of erectile dysfunction, which caused him extreme distress with episodes of depression. Attempts with sildenafil did not improve his erections. We tried intracavernous injection of alprostadil which enabled the patient to achieve a moderate erection. Thus, we instructed the patient for self-injection, which led to sufficient erections over the following months. We then restarted with tadalafil as a monotherapy which then was successful.
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [21] Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions
    Renganathan, R
    Suranjan, B
    Kurien, T
    SPINAL CORD, 1997, 35 (02) : 99 - 103
  • [22] THE EFFECTS OF STRESS AND COPING UPON THE DIAGNOSTIC INTRACAVERNOUS INJECTION IN MEN WITH ERECTILE DYSFUNCTION
    VANDERBORGHT, W
    VANDERSCHUEREN, D
    DEMYTTENAERE, K
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1995, 39 (07) : 865 - 873
  • [23] USE OF INTRACAVERNOUS INJECTION OF PROSTAGLANDIN-E1 FOR NEUROPATHIC ERECTILE DYSFUNCTION
    HIRSCH, IH
    SMITH, RL
    CHANCELLOR, MB
    BAGLEY, DH
    CARSELLO, J
    STAAS, WE
    PARAPLEGIA, 1994, 32 (10): : 661 - 664
  • [24] INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILURE
    VIRAG, R
    LANCET, 1982, 2 (8304): : 938 - 938
  • [25] Long-term intracavernous self-injection with prostaglandin E1 for the treatment of erectile dysfunction
    Canale, D
    Giorgi, PM
    Lencioni, R
    Morelli, G
    Gasperi, M
    Macchia, E
    INTERNATIONAL JOURNAL OF ANDROLOGY, 1996, 19 (01): : 28 - 32
  • [26] INTRACAVERNOUS INJECTION OF PROSTAGLANDIN-E1 FOR THE TREATMENT OF ERECTILE IMPOTENCE
    ISHII, N
    WATANABE, H
    IRISAWA, C
    KIKUCHI, Y
    KUBOTA, Y
    KAWAMURA, S
    SUZUKI, K
    CHIBA, R
    TOKIWA, M
    SHIRAI, M
    JOURNAL OF UROLOGY, 1989, 141 (02): : 323 - 325
  • [27] Role of sophrology and its integration in intracavernous self-injection therapy for erectile dysfunction
    Avenia, F
    Alei, G
    Viola, M
    Letizia, P
    ANDROLOGY 1996 - TWENTY YEARS LATER: PROCEEDINGS OF THE TENTH NATIONAL CONGRESS OF THE SOCIETY OF ANDROLOGY, 1996, : 967 - 969
  • [28] LevomethadoneRenal failure, liver failure and erectile dysfunction following intracavernous injection: case report
    Reactions Weekly, 2013, 1445 (1) : 27 - 27
  • [29] INTRACAVERNOUS SELF-INJECTION OF PROSTAGLANDIN-E1 IN THE THERAPY OF ERECTILE DYSFUNCTION
    PORST, H
    VANAHLEN, H
    BLOCK, T
    HALBIG, W
    HAUTMANN, R
    LOCHNERERNST, D
    RUDNICK, J
    STAEHLER, G
    WEBER, HM
    WEIDNER, W
    WEISKE, WH
    VASA-JOURNAL OF VASCULAR DISEASES, 1989, : 50 - 56
  • [30] INTRACAVERNOUS SELF-INJECTION OF PROSTAGLANDIN-E1 IN THE THERAPY OF ERECTILE DYSFUNCTION
    PORST, H
    VANAHLEN, H
    BLOCK, T
    HALBIG, W
    HAUTMANN, R
    LOCHNERERNST, D
    RUDNICK, J
    STAEHLER, G
    WEBER, HM
    WEIDNER, W
    WEISKE, WH
    PROSTAGLANDIN E1 IN VASCULAR DISEASE, 1989, 28 : 50 - 56
12345